|
|
Volumn 211, Issue 4, 1999, Pages 353-355
|
|
Recancostat compositum® therapy does not prevent tumor progression in young cancer patients
a
|
|
Author keywords
Cancer; Glutathione; Reducing agents; Solid tumors; Unconventional treatment
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GLUTATHIONE;
RECANCOSTAT COMPOSITUM;
UNCLASSIFIED DRUG;
ANTHOCYANIN;
CYSTEINE;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ASTROCYTOMA;
CANCER SURVIVAL;
CHONDROSARCOMA;
CLINICAL ARTICLE;
COLON CARCINOMA;
EPENDYMOMA;
EWING SARCOMA;
FEMALE;
GLIOBLASTOMA;
HUMAN;
MALE;
MEDULLOBLASTOMA;
OSTEOSARCOMA;
RHABDOMYOSARCOMA;
SOLID TUMOR;
TREATMENT FAILURE;
ALTERNATIVE MEDICINE;
CHILD;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG COMBINATION;
NEOPLASM;
SURVIVAL;
ADOLESCENT;
ADULT;
ANTHOCYANINS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
COMPLEMENTARY THERAPIES;
CYSTEINE;
DISEASE PROGRESSION;
DRUG COMBINATIONS;
FEMALE;
GLUTATHIONE;
HUMANS;
MALE;
NEOPLASMS;
SURVIVAL ANALYSIS;
TREATMENT FAILURE;
|
|
EID: 0032586915
PISSN: 03008630
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2008-1043813 Document Type: Article |
|
Times cited : (9)
|
|
References (9)
|
